Immix Biopharma Inc <IMMX.OQ> expected to post a loss of 23 cents a share - Earnings Preview

• Immix Biopharma Inc IMMX.OQ IMMX.O is expected to report resultson May 7 (estimated) for the period ending March 31 2025

• ​LSEG's mean analyst estimate for Immix Biopharma Inc is for a loss of 23 cents per share.

• The one available analyst rating on the shares is "buy".

• The mean earnings estimate of analysts had fallen by about 78.6% in the last three months. ​

• Wall Street's median 12-month price target for Immix Biopharma Inc is $7.00​, above​ its last closing price of $1.82. ​​​

This summary was machine generated March 25 at 20:15 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)